Garnry: Why no-one is talking about the crash in biotech stocks

Biotech stocks fell 28% this week from their July peak. Saxo's Peter Garnry on why no-one is talking about the crash and why he's still positive on the sector.

from Feed for all tv posts http://ift.tt/1N3Fbyn